Supplementary Data from Engineering the TGFβ Receptor to Enhance the Therapeutic Potential of Natural Killer Cells as an Immunotherapy for Neuroblastoma
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table 1: NK cell persistence. Fig. S1. Characterizing SHSY5Y neuroblastoma. Fig. S2. NK cell functionality against HTLA230 neuroblastoma. Fig. S3. Verification of NK Cell Sorting. Fig. S4. NK Cell Phenotype and Proliferation. Fig. S5. NK cell phenotype following TGFbeta exposure. Fig. S6. Neuroblastoma tumor progression and the correlation between progression-free survival and NK cell persistence. Fig. S7. NK cell detection in neuroblastoma-bearing mice. Supplementary Materials and Methods.
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362167709